本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pacira Pharmaceuticals

22.33
-0.3100-1.37%
盘后22.330.00000.00%16:24 EDT
成交量:95.10万
成交额:2,126.88万
市值:8.79亿
市盈率:178.64
高:22.95
开:22.76
低:22.19
收:22.64
52周最高:27.64
52周最低:18.80
股本:3,934.79万
流通股本:3,639.11万
量比:2.37
换手率:2.61%
股息:- -
股息率:- -
每股收益(TTM):0.1250
每股收益(LYR):0.1578
净资产收益率:0.71%
总资产收益率:1.35%
市净率:1.34
市盈率(LYR):141.48

数据加载中...

2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/01

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities